Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

3 May 2022

Policy

Read More

Note on Transferable Vouchers – April 2022

22 April 2022

Policy

Read More

Advancing Medicines repurposing in the EU

14 March 2022

Policy

Repurposing has emerged as an important strategy to address unmet […]

Read more

Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Read more

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

Read more

The Issue of Abuses of Divisional Patent Application

30 April 2021

Policy

Read More

EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

17 March 2021

Policy

Read More

Medicines for Europe Position on IP Action Plan – March 2021

13 March 2021

Policy

Read More

Maintaining the exchange of critical health data – An adequacy decision on the UK data protection regime

5 March 2021

Policy

Read More

Medicines for Europe Position Paper On Patent Linkage

3 March 2021

Policy

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]